Overview
Byron S. Kalogerou is the founder of the Firm’s Life Science Industry Group and the senior partner in the Boston Corporate Practice. He helps clients execute on their growth strategies by guiding them through complex domestic and cross-border mergers and acquisitions and joint ventures and alliances. He also assists early stage life science companies in their capital raising efforts. Byron has extensive industry background in the life science, industrial and manufacturing sectors. He also acts as outside general counsel to a number of companies.
Byron spent 18 years in-house, where he served in various general counsel roles at Tyco International, including as general counsel of its fire and security and telecom businesses, and as general counsel of its international legal department, a function he created. Byron led many of Tyco’s largest acquisitions, including the $12 billion acquisition of AMP Inc. and the $850 million purchase of AT&T Submarine Systems, and handled hundreds of middle-market deals around the globe. Byron also handled Tyco’s initial foray into medical devices and led many of the deals that formed Covidien, now part of Medtronic.
Byron returned to law firm life 18 years ago with a desire to bring his keen sense of the “voice of the customer” to drive predictability, value and efficiency into the deal process. Byron is a legal project management pioneer and co-chair of the American Bar Association (ABA) Committee on Mergers and Acquisitions’ Task Force on Legal Project Management. He is co-editor of the ABA Guidebook “Using Legal Project Management in Merger & Acquisition and Joint Venture Transactions”, now in its third edition. Byron also created the first-of-its-kind web-based collaborative deal management portal, which the Firm adopted and embraced as part of Client Central. He is also one of the Firm’s primary contacts with the Association of Corporate Counsel.
Results
- Advised Merck KGaA, Darmstadt, Germany, a leading science and technology company, in the entry of a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufacturing organization (CDMO) that specializes in complex injectable formulations, for US $780 million
- Represented Xcovery, Inc. an oncology focused bio-pharmaceutical company and subsidiary of China-based Betta Pharmaceuticals (300558.SZ), in its acquisition of a majority and controlling stake in Meryx Inc., a clinical stage immune-oncology company developing TKI’s in a range of hematologic and solid malignancies, including lung cancer.
- Advised Medline, Inc., a family-owned maker and distributor of medical devices and equipment, on the healthcare regulatory elements of the $30 billion leveraged buyout by a consortium of private equity firms, including Blackstone Group, Carlyle Group and Heller & Friedman
- Representing Biogen in various licensing and collaboration transactions
- Representing Johnson and Johnson’s Global External Innovation on various early stage financing matters
- Representing DraftKings, Inc. on various corporate matters
- Represented Scipher Medicine, a precision immunology company, in its various financings, including the Series A led by Khosla Ventures, its Series B lead by Northpond Ventures, and its $82 million Series C financing led by aMoon and Northpond Ventures
- Acted for Straumann AG, a global leader in tooth replacement solutions, in its acquisition of ClearCorrect, LLC, a leading manufacturer of clear aligners, for $150 million
- Represented Medtronic in its acquisition of Aircraft Medical, a manufacturer of video laryngoscopes for $110 million and Covidien, now part of Medtronic, in its first equity acquisition in China of Changzhou Kangdi Medical Stapler Co., Ltd., a manufacturer of surgical stapler products
- Represented ASC Engineered Solution, LLC, a leading North American manufacturer and supplier of products that connect, hang and support piping systems, in its acquisitions of Flexhead Industries, Sprinkflex, Basic-PSA, Megawatt Machine and Trenton Pipe Nipple
- Represented Take 5 Media Group, a leading consumer information aggregation and advertising company, in the sale of its business to Advantage Solutions, a leading North American provider of business solutions to consumer goods manufacturers and retailers
- Represented Dimension Data, a global infrastructure solution provider and an NTT Group company, in its acquisition of Nexus IS, Inc., a $471 million information technology solutions provider
Recognitions
- The Legal 500 US, Recommended, 2012-2018, 2022-2023
- Chambers USA, 2022
- Acritas Stars 2019-2020, listed among independently rated lawyers
- LMG Life Sciences, Life Science Star 2016, 2018, 2019, 2020
Community
- American Bar Association, Committee on Mergers and Acquisitions, Co-Chair, Task Force on Legal Project Management
Credentials
Education
Vermont Law School, JD, 1986
Harvard Business School, Advanced Management Program Certificate, 2001
Dartmouth College, BA, 1983
Phillips Exeter Academy, 1979
Admissions
Massachusetts